Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Ureaplasma parvum serovar 3 str. ATCC 700970, ATCC 700970

>UU307 conserved hypothetical ATP/GTP-binding protein
MNNNQVDDELDLENFNYQKALEIPNIKAINLTEEEFNLYFWDIVEVYRSY
LNNLNNQNDSYYIYQLNRNEYNHLCLVVVKKENKVDKIKRNYILNTIKNM
DYNISLADDSQIFSKKTEILDANLLAERNKLINFFLEEARKNKKNTLIKN
NNQQPKSAFIYGDFSVGKSIITQAYTNTISLKYNLKIAYITLNDLFKNVI
QFFNYKDTSDLVINELVNLLSNVDVLVIDDFSSVNLNYWSISTILMPIIE
NRLKSTRQTIFISNFSIEQLINSTKNTTNIEEQKTKLRLFNRIEYLTYGN
IFKITGPSVFKVVNNS
>UU542 unique hypothetical
MKKMFLLMKNMMRLFFKNKTLVTQLSILMIVSTVVIVATTITVQRLQKSQ
SDIKKIGLQSDFLIDTKEQDNINFNEIDVSNNLVKHNEKLIQLATFNQNI
LKNSNNYLQLVDNAFHNHNLFWPTNVNNQKIDVLNLEGNIDWNKINQLKL
QTVFWFENNKENNQNFANNYDDLVYEYHNSKNQLVGFQNLDGGHILFKTP
ALKSANGNYETTFKINAAIVQKNKPFKSFFNFDKYKELGFKNKSYFTNPV
LIKNIDLYSKQVVQTLNDRSNQSIDFKDYQSTFQAIVDTLETNTINKDFY
SVNLHVDFNTLSTKYLLFANYLKNEGIDKNRYINELKIDNYKQKYLDLFQ
NQVLIPKELIDDPKKIEEVQKIIAKAKALLIAKIREETNIFYENSQKSAL
ENKNKIRDYEMQLKQINIALQNSNYSNNELIQLKNEQKVLAANLDQAKFK
HFLYNDLIKQDFRSILNNYNIYYRKHESAIYNDVKSDSNFIVTNASNPTY
TQNGLIAPRNQWIDNMVQINEKNKNSQNPNKKFKRIFINDDNSNKINNFY
DLYSNYIKVIQILKNSYEKDPDTDKDLLVEERDYTPWINTSLINIYQLPQ
FFNILFNQSEWLLSIQYLKEMSDYKKYLLQIFEPYQDKEWIFNLKHKDWQ
DGEQVVAIYKNADSNSDQKEYYFNGYVKNQRAYINVKYNKNLPTRLKLIN
IIKQNQINQKNNLVNVLDQDLNDYAKIINFKKGIKDINTNQQSVYDQWAL
NNPQDYAMFKIWLSKIIKRYYFLRFSNHLMDIQFKHKTFYQKLCYCRLQL
ILLIVVQI
>UU571 conserved hypothetical ATP/GTP-binding protein
MKKAIKQKLMNLVNLNPHDSIILTRLSSSRNIDLFKYIKKEDLISFVNGE
ISYVELNVGKNLNLFEESLKNALNIGEFLEILVNYNVNLADNKINLLQRD
FHANKKKIIPLAIEQLLAFRKKFISINRLAKNYFEDTTVWPLYFTFNFLK
GKLLPNDPFKSPLTLFKVEIREEADKIFIAKIQDEPIVNEKIQIFLKKGY
QDFKVETTELLTNYELSSTIKMIEDMTGQKININENEFVPFMNENETQIL
DRYTTFEIEPSAVLGLFEPDGGALKADLHKIIEMDVDPFESENDGLNKPV
EYYEDKVIKEQMVVEIGRPLNIFQKYAVASSLSQNTLIYGPPGTGKSEVI
ANIIFNVLLKGKSSLLVSEKRAALDVLTERIGSLSQFALYVYDLTNKETF
FEKISNLNDLLGTQWYREQSRSTKIKEIEPIKFTPEESMFFKNYEDWNSE
LLQLVKKHWSIEDYNDGIYKMDYADYVATKNELGEQIVKEWLTPQQFNEE
NEKRTTLFEEISTIFNEYNLLKIEDLFTAYLRFTSFIKKYKLTDNYSSIE
ILKHLKMITNKIQTNDELVTKFLMHANRITKDIDNYYNFLAEHNLESNTI
FMNKSIRDKRIFIDKIGDYLKFRKDVIDKDFSLQSKTTQELNEIIDLCDN
FFTKHKKLLAKNEWFSFLIKNKDRISAFLSIYNNASDENKQIIFAEFISN
GTIITNADPSDESSLSLKEIKTRNRDSQEVIELFIDFLNNIEYLSKPKMD
QIASYREFINQDVDFLSKLHTLAEIYTPTMQDIIREWSWLSLPYIKTLYL
EPLILFDLEKIGKIMKHVSTLITHDQFKKLKVIVLWDEITHIIPMFSETK
GRLLQDIIIQLRRESMRSAKIVGEIVFKKYINNLRNYLTKLPQQEKDEIT
NALRIASSRSWPSISRYLSKYYTALKRLFPIWVARPDNVASLIPLVENEF
DYGIFDEASQMTIERSYPIVYRCKTKVVSGDDKQLKPTSFFINKLADSDF
EIDDFDKVDSLLERAKTSWWNEYHLKNHYRSDSKELIEFSNKYIYNNNLE
VATRQGAFEKGIDVINVNGVWEKGNPLEAEQTIATLIDNWKKYEKILIVT
FNAIQASLVENLLFERMNIFEKGLCDKIENNEIVITNLENVQGNEGDLVI
LSIAYGPNPEGNLRNNFGPLNAKGGMNRLNVAITRARKKMIVIKSLYGHQ
IQVSNLNNQNALTFKRFIEYVDRINGQLSINDSLESLEQQTYLEFDNDLV
KEIYSELTKKLSNKYQIFPNWNIGTKKIDLVIIKKETKEIVKTILLETWK
ENRSVQIMFEDIDRQYFLEDRSYSTYRIKEYEWYIDKHKIVSRINDSLSS
NNNNNKIDYVLWQQNNF
>UU259 unique hypothetical
MNKQKRKISVLTSISLFLIISLSIGLGLGLIKNNENSITSKVQKSSNFFI
NDLSKQLFLDVFNQDKLELNAYMYDQNNVSDQQLLDLKFALTLLNPNRLD
INDDDTIAIMKNNAKKIIFQSLSNNWYWLFTNLKSLEFSYTPYKPNFYAP
YINEKQDFTKSSIFDKVININKPLTNYIKIKQKLFDKENYRSVDVYYLQF
GDHLILRLLKFNKKNHFDVRFDTDLFQFNKPIINLELIAKEMQTSIDYHR
EDNFKKDILDYKKNYEDYLYYDEKLNSSIYQQGLDKINKEYYEVNNFNFF
NTKKPLFQKFSYQMFLELKDKLGFKRYVLRNIDQKEVRARDHFNDNEKKQ
QNKNYFRSFDKELNYFQKYIDHNLDININKISKEAYITQKIIKNLLLDAF
NNNDVQITKYLIQQNDKEYQNKLIKQLIEFSNYFKNQKTPRDSNEYKQKL
NDYEKIFSQNWYFILMNLKHFELSFNNWFTLPKQINPITKEMLGPSEKYL
KRLKKLKPYEDYYFINNYLEKKQEGDTSMLIGSFKDLYITKNQSIFNIKI
DFSSSENRLSLNPLIYFFPKTKNKLSVDLITSIFHQAIFHQNKEYYQLFE
TDMIDKYEYGIPAQMLLLWRE
>UU475 unique hypothetical
MKHKKYKSIWLKLSMISAIPLLATIITTCAKVDTKQKAKEELQSSLNKAV
LLKEIVDQSSYEDFKKIYNQTLKSNLENINKLSEQKLKQEQQTIKNLITQ
VSVLNELDSIKNMSDLIDVVELENTKKQLQDFLNQYEKLLNQASVDTTII
DKLKSDAHQKRLDTKALIQKTILDLANKIKSLIKTSGLNKNIVELENDIQ
KLVNNDTKANFKKLYEDFKLIYTKLNDINDLINKELKALPFIKKLDDIVN
VINTIYEQNHHFLWFDQTKLTNLRQILIKNINHVLNVKKTLEIKEIKTLT
NQLLVDLQNYLEGLKMIALESENSVNKLISIIESLQPDDYNPYYSIEKQE
NKQKDENNSQATYNGLEHQIKSLKSIINLFDFNITNLSIDAIYNLNDELI
KKFQKANSQINDVVIKIKQTILSNFKQIYLFKYFIKHLKEFNIELNNEND
PIKKANRIQTIQEVLKSYEKDLFLNTKINLKLAPNEVLTVNNLEKIDLTY
ASDSLQKPQELIAYLELNNNQEREFSKELENLSVRVFTIIDKKLYIPKAK
ELIDESKKIIQTKNEHTNNKAKLQRLEKFTSFVEQGISNENVSSYTLNLY
IQRLTKLIEEIKKPQH
>UU165 unique hypothetical
MVDELEKNQVQPQETEENKENALYDEIDKRIQKQFENYLKTNEQLDNANK
LVEAKLKEIKDLENTFKQREQELLNKIATLEQNQQFVNIHQEKPVVEDAN
SHFLKFFN
>UU492 conserved hypothetical
MAEIITRGYLVARQDYDVFDEILTFINEYGNRFIMFAPGTKRITSKNARA
LFFGNFLEIQFFYARNDTKLSKLKKVISLDQIDYKYENTYSMLILSELMT
KVVNFNVEFYQFYQLILEYIILEYNDYYISCFLLVKFLIMNGVNFNFQAC
VHCNSSKNIKTFSLADHGLICINCESKIINKIDYEPKALQLWQKLYFATQ
IKKDEDKDNEIIYKGLLKILNSVLYDQLGIYLTIIKNI
>UU043 conserved hypothetical membrane lipoprotein
MKKLKLITLSLSPIPIVAIMATACSTTKKEKEVDHKQDELTTINNNLQLE
YPQNKDIETSAAIKEEIKPLNLPSGVVFSIKEISPKANDESTLIVKYTLK
KGNITKEFKKEINGFKKIRKDQNIANLKDMHDDFKTIFNNIKLKDTFDFK
LKGLFNSNFGEYDKLLPSQIINNFAQGVETRINTNQDRLGIEVIDVSYPN
KNFGSANREGNLKMSLLVTDKKTKQVFIKSIIAYGFKTNAMGLDENGSIP
GGGADLVKPKVDENNYFNKTQLERYEIDNQAYLNGLKGQHMGKTWQQVRP
ELGDNEQKINEFDQKAKGVSQDAYASAAYKGFTLPVYDKNGDFKGLSINE
SSYGQARSWVDTRGRDEWKTTGLPRTLPNEKYRDEALQTLGISSLTLKDG
KKDTWDKSSGTTWILDYQKTNDNKYPTKWYFATNLHVADTITDKTTSIDL
MKLMDSVKTKTTLRLSNLDENIYRFGFASKNNKFLLNHGLKKIYDGRNFL
KTKPTEYLTEQQKEKYKDAGSFVDFAVFELDFEQLKLLNVWNNQLNSNGG
VITKYDHSSAQDLAKIITSDYANHSDKQIKFLSKSYLNDYSKIDVPLRST
SYKFEGKDELFALGWPNSTRDGFFERYVDDDQTKYRTTDNFSLWTNSDYR
FFGKLTEQEGGQPAFPTERTERGNYLSYAIGYRSFIDKPGVLDAFISAPH
TGNDLYKSLDGKKYINMGLEYMPRHYAPAGGASGSSVRNQNNEIVGIYHV
SNEFASTGLATAFRSEGYDYKGLYGDKYKELPQYDLIYGGGKDQATGQSY
REKMKEIYKNNNNIKTALFPNGFDQYDEKFKFNNNQSK
>UU196 conserved hypothetical ATP/GTP-binding protein
MLDKLIKTLKNPHSIDDIVGQKYLLDEIGIIRRMVNHHQVFNLIFYGPPG
VGKSSLAKVLAQDLKVPFAFFNPVVDSKKQLMQIIEQALDLNNFIIIIDE
IHRLNKDKQDILLPIIEANKIKLFATTTENPFFVINPALRSRCQLLSLKP
LTSSQISERIKTLINVEEVFEPQAFNLLINKTNGDLRAVINTLEIIYLLY
KEHKVDYVLLKRIMQESYALGSSDGDEIHDLKSAFHKSMRGSDCDAALYY
LARLIIIGDFEAIYRRVSVCVHEDIGLANPNLCLRVDQGINSCRFLGYPE
NQVILANLVLQICLSNKSNSVYLAYQKAFEDAANGKQYSIPNHVRDAHYA
SAIKLGVHGYKYPHDFKNNYVNQQYLPRELTNKKYYVPQNNEQEFKLNQN
QQKFKNNN
>UU167 unique hypothetical
MKVELYTNDWIDFFKNIAIAWFKTKRYGNKRLSSIEQKQVNKLIRQEFDQ
YVEFKIISNLIKDYNDNMEKVISLYGANLMPLNLAVQKLYPELTPTEQDE
LVKELEHKQKLENGEFENE
>UU328 unique hypothetical
MNLINKELFLITGDNRLKMDQKINEIATSFDELVKINDQEISLISFKNLI
EQDDLFNSNKIYLFKNVNWFENLEHLKNVSDLIDYFFNNHVAIIITIEST
KISTAKKIQETIAKFNHQITFMTYTNENAMAFLKEELNQRNLSLNKSIMQ
TIIQKTNFNINFLNNELDKIELINDFLKNHGMFDINNFICDYGEYQIFSL
LNLLYQHKINESINLINKMLIDKIDELTIINMLATIMSTHYLIKLLHEKK
YNKNVISSSLNQKPYIIDLNLKLIRNYSAKFLLKKMYDLLQLEIKVKENK
IDKYFGLINWVLNF
>UU389 conserved hypothetical ATP/GTP-binding protein
MQDQGVNNKAIKQKVLNLLSTDTRDSCIRTRLTKYHLDISHTFNKYELQD
FIEGKINILKIRNFININTFENDVKNINSMDELIDYLQDFNLKLKDLLST
RKINEWSQDFVFYKNERIADMIKAIESQPKKFEYLSREARNIYAQTGVWP
LYIAKNFLIGTTPKASNINAPLIFVDVEIKKYNGEIFLKRKNTNFIVNEK
ILSFLKNDYKNNIVSLNEIKNFSYLEIQTLIKKIILKDHLESIINNNEFL
NLKQNEINEQFNNFFLYDAYVLGIFEPHGGAIKNDLEVIISNNIDPFDEE
INNVNQQIYYKNYHFLAEENKLPLIQINRPLNIFQKYAIHSGLVKNTLIY
GPPGTGKSEVIASIIANVINDLKSILIISEKKAALDVLHERLAKINFFTL
FIYDTNNDDQFYNNIFNLIEKIGGLRFIENQDLNQFNDFKYKNNIISNIY
YKKIHELKKEIINITSLIKNLHNEKDNNDNNFANYLYWLSRFNEVEIRFI
NDPLLINEINNLIENYSYNFDEIITHVKASYDFFKKYNYEFSKNNFLKFK
EESEQLNKLQIDFNLITKSLYQSQTFLPRIKLLESFLVKNNMTLTSLIYD
DVNLLSNTYVEANEFYTNFNHLLKDDFKKFIEDNIKSHSLFFSHLNTLKN
NEWTYAFEQYLLINNPFAKKGLFKKIKGDEKKLWKQLDLLKIYINNPFLS
KFSFDFLEDLIKQPIEIFNVENLVYLNNKHLLNKAYVKDLYENAFDKNLS
YELIYGLKDLKLNSEQYDIIKNLIKYQNEVLVNYQFIKNTDFFNLCKKLR
DANIQFSKNADEIIYNNYLDYLQIKLVTAPKQIQTKIKEIAQICRLAKKP
NIVKFILKYYEILRFLFPIWISKPELVSEMLPLISKSFDYGIFDEASQMF
LERSYPSIYRCNINIVAGDDKQLCPTNFFINRQENENDEFELADVDVAES
LLDRAKTALWSEYLLKNHYRSNREDLISFSNDNIYNGDLHFASKNGLFDP
GMEIIDVEGVFENENVIEAQKIMEVLKERAANYQKIIVITFNIKQSELIE
NLILQTFSFNDVVYQRFENDEIIVTNLENVQGNEADLVILSVTYAKNKEG
ILRNNYGPLMKKGGANRLNVAITRAADKMIVVKSIKAVDMMVNINNDNIR
TFKNFIGYCDEIVHLTNQNKFNDCSHFDEEFLTSLEKTILKILKDYKKTN
QQILYKLKIGNFKITFALYNEEKQKIDLLIFIEEFNEWKSYNLLEIYDQF
NFLMDRGYKTIVINDYEICLNYNQVKNNIIKLID
>UU476 unique hypothetical ATP/GTP-binding protein
MKLTKSQQKAVSQLVNCYLESVNNNKKEIIDFQAPTGSGKTFIITNTINE
IIKTNKANGSPQKLIFVIATLSSADLPFQLEQNMNEYKYYINGLFDVELK
ESPSSKSAKKDSSYNILAEENKVIIFGSSSFGKGRIITEEGILDAFLDEI
KSQGYTLVYIRDEAHHGGNVNKTKIFEDFDEKIHKNSFKKEETRFEYKIQ
EAASFIIKMTATPKGIHKLVFIDEKDLMDDDTKLLKDEHVYNLEIKELKE
ENIDDELLLTTACEQFLKIKEQYSKAKELKNIRPAMLIQVENEPNKEPQK
SEFLDKIEKIIKILEKHNLSWVKYFSNDKEVQTNILINKKNNKISLKEIS
KKTSNVDVILFKIGPATGWNIPRACMLVQLRNVSSKNLSVQTIGRIKRFP
NPSFDKNEISYNSISNQYFIYSNIISEDKIRQTLILKDKYKNDRFFYGEI
NQEKINNYLNGETYKEEIVEKFEDSISNFEYYVNEEYRENFVKNQYLEGE
TSKIEGKTRVYTKIKNSIELELYIIEQLRKYKHLFPQKIIDFLETKFNEW
EKRWKLNISINMYWYVIIKEYLDQIEKIYKNSLEQMKKDNHELLFKLQNN
KNLPNQNEIFIPIEKYKKCENMLDLNVCDKYAYKDLKEQNHYFDSLTESK
FANRFLSLSNDNDKIKNNVELWTKNPVFHGLKYQYFNEDGQISNSYPDFI
LKIKTHDQKDHYLYIEVKNLYSDYDYEKTKLLIESYQRYIENKNNNDNLI
LDELDKAEITILVCYINMKNQKDFYFYGASSNDVLNKKVNFDLLKKTSIN
KTPEQLVANKAKFIIDIKHLLDFLL
>UU152 unique hypothetical
MKLSRRLTNMTNWDKEHALSEELRQLKDEFEDLMDDLARINKDLDFNIWE
RKDLEYRKASYETDIESIRLRINQKQNEMMEIIKNDK
>UU271 unique hypothetical
MFMFDQIFKKRKRHLNFQIFIFFFVLILITFLILWIISGNVQTIIDFIKK
KIYDASPQLKYLTNIQIKPFKNLEEIFDFIIKNKNLIKDLQNEPEILDVI
KNNPQILKTLNDNREFLKQIVEYKPFAEILSKQPEILKFVQNNKELIKQI
QNLPELLDLIKKHQNLIDHLKTNEKYIEVIKANPQMLKDLYHVDDNLFNI
IKTSLENDKENNILMLAIKYSVLINNFTKNLTLQEWKQIIEFYKTVDLNK
FIVDDNLFNIIKNNNQLFEVFLNNYDYIKNLEDNQKIIDIIQQNPDLIDD
FKKIDFDLLTQKRNFVRALIKIIDYKQPKEIQFLNKKVFLDFFKNKSEIT
NALNITSLIGFVLFIVIYTIFIFASFISHILMLKQIKDFNKIFKEAKLKK
IYLISTLLLQFLFLILFIINFIVLIILVVDYNKLKAIVLNSGIKRKVEDS
DARLHFL
>UU388 unique hypothetical
MALSKHSIGLIKNLKNKGLTIKNKEKFISFLFNYGVIRVIDGYSFFLKKD
NQYVKGLKSKDLINFVLLDRKIANLMGDCIMLFEQQLNAIVVQNFLKINN
LNSKYVIDMRTDPFIKFESPKHYEILSENIYTYANSSNLLSQFNTNAQEI
PLINLALSWTLNTTIGFYRAVDNNVQISVLEYFQLNHITPLEFIDILHII
KHFRNSISHNDMVITNSFNDNVGAFAKSLKLKSIKKVVGFLDVAAFLTAF
TNDKFHVLNGNLHIKILQAIKKAKFKGVVLEHINNLLGVED
>UU574 conserved hypothetical
MITDKLIKELNEITRLYYKNDRNQFKKSLINIWSKTMGYTPNLQDPKTYN
EKLLYMYLNTDQSKILEIVDKISFKKWLIKHRLYQYQVPTLAIFNRQNQI
TLLDLNKFPKPYIIKLNNSTENEDLYIIRETTSQAELTQIITHFNNILLN
KKINHPRNFYETWCYSQIKPQVLIEPLLGKQTLVADYKIFCFAQEQFCLY
MNKDEIEKNNWNWDFLKSNIFDLKNNKSILNHEIINFDFSEIKDVCQKIY
EVLKNDFKHFRIDFYYVDHRLYIGEITFNTSNAFFTFWDDPQWKQKDIEW
GKYWK
>UU143 conserved hypothetical
MKRIKNRKWWKFGGVLFLLPLASFLIMCKNQEAPKTNQEAPKTNKENVLD
DFDANIINIENISKPKFINQNKTIINLKLKKFNFKSPNTTITLTYKDNNG
HKFTSDPLSINDEQNYDFIFSNLTPNRKYQIQNLTFNNQKRTDIYLKTNL
NNAIFSIKPIPIKTNNFKIKVFNQNALISFSIPKNSDVRVNEKIALEFEN
LSSNLVPNNEIISRIDKNFNVEFKLDNLKLNNKYRIVNLRFLDTNPPNVS
PNIFEKLSNYESSFIIPGIKTNMHNHKDLNSNDKKYIDSPYNTKIELNDK
NNFNDKVLPDAFEQQNINIQEVENLNQDILNQNELELQKYFSFISDQANL
KDKDFQNYSFNDINKNSKQEIKFKIKHINIDSSNKKAIIELDSSSSNDNT
KLLEANNKQLLIKSYDYNNPWSKIVSYEKKDNNKMIFDLHDFPKDLKTFI
ITHIRFDDNITSLGKIKENSFEYYQNDKEYLLKSLKYYFDIKENQLYGSA
CFNFNNDDFKILKNKTFVFKYEIDTKNNILNKYIPLNKYINVDFKNLAQF
KIVNVFDGLNYKLESIKIVNKNSLLPYNDHVNIQNANNTNFSVWHKVYPK
QNIINEFFDDSLIKDEFNLSKIDFNHLWKNNTDQKNIPYSLRNLISLTLH
EREYAIYKHNATNGFYLYNTITSNKDFNLIKNNKESYHLNSLIAHLAIKD
EGLKKDESAGFFLEKDLNDFDNLNNFKDEDIVFNVDLELDPNLIYESQLV
DKNMRRSHVIIPISYKVIKKQHILEDVEFSLNYALGSEAYENHIYQQIKS
QLKFNVFLNGSKIKVEVKPRNDNIKLYDYVWKHNNSNQPSYFIGRYDFIV
NWLTNNNEVIIDKKLEEFKKKSYTARILKDNENEMSKAAIKQVRERTITF
SLTSDGTWNFLGKVKPNDPNDYRYYMLTDHHVIGSGGSWYNPQINWAGKM
EYESINLNKKTIYDDDGNEKYTYSNFADYTVVIPQTISQNDLNKDKYQPY
YNYSSVNNQDTPGKNQLQYFAFPFKLKFEKVMDFCLQKNNIYKHYNALGR
YDDKISELDWSVVSIDLKPIFEAFKNQDLNKPFIYNNKTLSPEETSVIKY
FLSLKNIKPLEVSPQTRYVRSNQDVDWYIGTFPRYTNTNQNSMGVGELRY
REYNIQKIDSVNTNFVTGGKGVLYKSDIPYTTISTDYIDAAGGSSGTSLY
DEQGRFVGSIATGRTPSKNGHPTWETIGWSLIDSQISGFFGDRENRANNS
SIIQQIKQLAYLYPEKYEDIYK
>UU194 conserved hypothetical
MNKPIIKEVIIVEGKTDAQKIDQLVNAQIITTNGSEINKKTLALIKQAQL
SKGIILFLDPDYQGERIRKIITNYLKDGIIKQCFISKDNMKNNSKKIGIA
EANNDALLKALKSQGTFVINSIESITWLEYLSLNLNNKKIRLMLCDYLNI
SYCNHKQLFKRLNMMQKTFKEIKIIIEGF
>UU293 unique hypothetical
MYNDLLDSLFTKLSDKSILNKLLNDDFLSIGSILKEIFNINQPSQLIKVI
DIFSIKDITAQDYVNVLNVIFNDIGFNNQQTKQNITNDQKYDINIYFEYL
KALVEHNFSELTKTKLKEIVKLFVKDVMNDDHHNHLWKKMTSFISHKLSD
LLIKKIQVLTPQKNEYQQLVNNLLNGIDFKNVVQNLIVEGFAKIIDHQQQ
LKNSQNFGDLIQKVINIDDVWIKKQLKQLLSAITKDINLTKATSTTIINS
YLNYFEIKNLTEEDKRNLINIFDKILKQIPNLLYLQNIVDQSVDFLKVNI
EALINHQPLKNTTWNDFINKNVTDISALSNLLEIFETNEITNNEWNQLIT
ILINHAPIDKIEEIIRNITSNSIINNKAQKQDIKKQIDKIYLLIKKVLQT
QTLNKSHAKTSVVKINETIKTLIDSLFANQEIKTLISNTLSNWIFSSNLA
KILNVDEDQKNSLIKPVVEFIISSNDLKTILKTITNSFILHASELANTNS
FEELIVKLISFEQTNLKSNLNNFIQKILQNDKIDELLARVIFKQISPQKK
YDQIQQINKDKVVTFIKKLGDNLTKFDLYNKLLDNLFSSITNQTNLTKLL
SEQQDSVINFIKTIFDFSDPKQIISLIDVLKVNEITSNDYIEVIKSILDE
IDFNHFFNQAVKNSNLSNYPLNKHENDNDSKLDINKYYIYVKTLFAHEMD
STSKEKLKTIIDELTKKIVENNNKGLLYNLGNGLGEKLSNLIINTFPGLT
NLKQNYKTLVQKVFTNQNLFEQVQNLITYAINSLIDHKNEYQNCKTFGEL
LTTYINKNQTQIIDKLKEAINKIISGSSSLIDEISTSFANTIKTYFKLEN
LTVEDINKLKSFINFVIKNIFNLEYVNDGLVKLITTLSSNAIKIVDQNTN
FVTVMQNDVISYLTSPQQIAKLLQIVDLDKNDDILNFLKVILSHLPQNAY
TILFGNKINLITKNTNQKTNRSVIQKYTILDYVKTILNSSYLKKQDTIVK
IKHIFKDLLVTISKSSQLNNYIGELISNTFAQKLSNLSGVDKQYSESFLK
ESYKFIISDEKLIKIIDEVVNDLVDHKDEYLKEITNNNQPSINIILNMLI
KRNVDQQKVDFVPFIKRYLVIDSSTQFMAQYLFKTLKLENTNDQDVKIVQ
TFVKELINQIDQLDFVNLFIDKIFTLIKENGLDLFTKEEGIKKVNEAMKT
FGLTETTNLLKIAKLVEPNKIKPQTIGDLINLVFEKSPLAEDFESITQDK
NPLYYGLKNLKEDSLNAVLFASGKKKIGEAAKVSEINMLDAIQHLINKLW
SARAEYAKNHPNLEYEQDNPYMRSLIHLGIVMQWYVHETYFRNVSGGLWW
TGSDSLSGEGRVYLLLKADMGSESEKRVRSMIMGNRGAMLWNTPKEWNYN
KNDFLYMITYWKWRTNSRFNDSKEKNKATYIFKALKRGYGEKVKTMK
>UU308 conserved hypothetical
MDIVIKKNCNFVKNDDHLYSFYTPLIGMQAVALYSWFVNRENIFNKKGTI
NLTHEYLLDELNISINTYNELITKLINVDLIKIYSFENNSQQVIEVFRPL
KFSEFINIEKFNEELKNNVSLNHYNVLNLLNKENNIDTNRLIDLSAQFKT
NHFNNLENKLDKIKKIILKEYGLSLQIDESTKLCLINFFKKYKFSIDQML
NLIKNNLINNIDFLTIDLNKLELTIFSNMEFEKNKTKFQYYNIERDFNIF
NKNSNLDRFKNVINDYNNFKPSDFLKHIRKEKLSLKDKEAINLLTYDKSL
SDPIVNVILDFVLFKNLGRLNVKYLKRIKETVLGINIKDEYEMIKFFQNK
KNDHKELICEDSDNANTFKNTNFIEVKFGDL
>UU422 unique hypothetical
MNIKKIKREFNTHYELIKKEIKNLNEYKKELEFLIATIYFNSKMVFKEIS
LDSWKKFSDYVYRFFLIINKNNQSQNFDLDCWYLEIKELIKVLNISNFLL
NKQLEQIYLKYIIFYWYNINIPINYEIDDFNIICLRNKAFVDCMQILQEY
YHINVDILINLVIKQIR
>UU017 hypothetical
MLEKIKIIDTHTHPNIEPLIEEFDDIIFKCYEQGIGLNIVGVDLKTSQTA
IQQAKKFKFLTCSVAIHPNDLHNIENDFVALEKLIAENIDYISCIGECGL
DYYHEQNYDHDFQKHWFKKHIELAKKYHKPLMLHIRNAHDDAIAILKELA
VQDVIIHCFTDKKEYAQQYIEMGYYISYPGVITFKPTKNNQLHELYEAIK
ITPLDKILVETDAPYLTPVPKRGQTNYPYYVLYTSAFIANLLGITHEKMQ
KILLENSLRILNFKK
>UU440 unique hypothetical membrane lipoprotein
MNKRHLVTHSLKKKLFIKTSLLSLFLIAPLIIGCTTNKSKSNNSNKLSKQ
IEIKENKQQEKPKTKELSPIIDIPKNDYYKVLYANNIKSFVYDGKVWDDQ
KQTYDLEFVNKLLAYIDQHISNLVDFELVKNNQNKPWFKWLIDYYMFLNV
TYFIDNKPKFLANSIKYISLRDPEHYFDEATRIFKKYYHPNKLSSNNKDY
FYSWYNFIYFAHINHYYNARELYKYYNQKFNLDLPSKYINHSYPISRIYK
NDRYYFSNVNRILFKIKTYDKTRINTLFLAFKKLNQSNDENKNLIIKYLK
QENLIDQNYEITNKLDFNIFLEKSFLNNKEYSSTKNELKRFFENINDQLN
KFNLFVNAYWYDNKYYSISTSNTKLMNDKIRFSIINMLWRDYDITDYIKA
KKDELIETNPINSHYEDRYLNLLKQLYENEWQISINKDKNNEEINQLKTK
NESLKTRMQNIKNEFLQYLVKMGIIDDAKELADFSVSEFYLWSTYLSTK
>UU068 conserved hypothetical
MNFKSTIVNKKPIDWKHTIVLEELNVDPKALEMHKERINTVFAKQTEEQR
SQQLHNIIVRENLFNKAMTYLADFYEIDVNEEDIKDLAPRIKQAFGVEDE
KLAYEIAQKIIAKALIFQDLQKEFTIEIKDEELTKILESYYEETNLSIRD
FKENKAQWEAAKSTLLEEKTTAFIVDKFDRDLSILEANIRKKIAEQMELD
KKIKEIQDNNKSKQNADK
>UU335 unique hypothetical
MFYINLRVKTMMEKLKNNKTLFLNVEQAQKLGINNPLTQEIFLDDQKLKV
HLINSIKDEFYLKKSISKGYAYFNSLEQFKTMELDVLDNYQFAKIAATNL
DEYDQLVYTKTRQYLINKEFWTNDGLDAFIGDDFKRKQLTSKEIVNLKTK
YDLWIQELHFNNARISKQIHNLSIHGQNKLDYEKFYDKKATLESNLDILQ
ILIYLRSSLLELDFDDLFKDDQNKISIRQLLVNDLEYLPFSFQRYDYESR
RNFIRNSRQLVDTSIDFDDLEYDFLHNKKPKQELEKNNESIKIAELKKFE
NSQLSDEQQSNLEKEFYSIGRINCFDEVSENKQELNKEQLVIDKKNGYLK
PRSYLRHHETPFMVDIENRVDFLMAGYEIIKNDDPYAIKQEILKNTILEQ
QKLVEQDDHDFKVKNDDQEANEELLDNTDKLENQDSTSAVEFNDSSEVTQ
VVKTDENVDNLIKTKQITSFNDLKQEQSSQENIIKNDLSSIQIRLDEIIN
VHEKDTKLQTELNSIMIDSNEKNIDDSLNNLNEQIRIQDQELESSDNQNV
IIEEEINTKNLNNKADVGVMSVEKKYEPEEEMVNFEFEIPENQKESVNQD
VLNSNSIDNFKEEKAKENTFLTPKEIENNDLSSQIELTPADFELKTQEIN
DETERLLDELNNNKPKEKKKFWTWFNSKKR
>UU451 unique hypothetical
MGLFSKKNKLNQKLTEDKNINITDVLDNNKDIYQLYDETIVTKKVKVRCK
NCGVFMWVDYTKTIKSLRNLALTNIQQEQIPVMDEPQILQDCNDLSSAPV
NNQEDDIVNEHESTPIEPLHEEVEPEPIKNENQSNEEFIQENIVAPVDEV
DNSVKEHTPFTPVSFEFEEPVFENIYSNQKVYAENLFLESLFSEKESLIN
DDQNDFSWLSKYVSVWNKRDEAELAQLVYDECLLAPQSSVFPNNEYFIEE
EYEHIDPDNHHNKHKAQRHHRGHDLIVKKNGKEQIEKAIDDVLPINNGLD
KKQQLLLKTVLIEEEFQSDPISKKTWWETESANKSSKK
>UU455 unique hypothetical
MEFDMKFKKILLTSTLSVLGVISIASLATNCSQTKTKINQYKITINKLDS
LNLTSNLTTKQALKDVLFSKEGQNEFLLSNVKKVVYDWAKNNNDPKLAHD
VSEYNTQLDEQLKRIKENVKKSYPNDWQSVLQSELYDTEGGSEKSWKEAK
LIDQAYKSITSSIFDDNDNWISVLNDQNQLIDAYSNDATKLLENESTFKS
TKIGDRNKIVAKTNNFLQKGYANLFNFLIDDYIKYNLPLSFANIEFKYDD
LKNQNIYNKDFFTKIPTSGTSPNFPWFDPKPTDNKSTNTTTNYLEVAKLL
KENKYLDSKDDTNNIDKKFNNNNDINKYLSLNDFITQDNTNLTLSVGLLA
KFLSLFGNENFGIYQLDNLDENNILNNFISKNQSNANTNNVDLFYPLVKK
DKTAFLNDFKDVKAIRQINDLKNGYTLLRNENSVDLWGINNFKRLQQAAK
IGLNALLTELKNDFLYNGALYLNSRKSNSVKKQGYDIKAKIKDYFNNNKE
RLLALYIATHQNDSDFLFKSNLKNDSKVFAFDQRTINIIKENNEIHLLNY
YDNLIDKLNDKLIKFNKKTFIIPSVDSLYDNGINTPIYLIKDQNQQISLF
QTLKIKLVGNKNLIDENQKLSTMINDYVENFDIKKHLVANNKNSQSIVFD
DYVINKVFSKGINSVFANIIKQEQIKKSVAKFFEFNDFNFKNNFLENQEL
LAAFNQIIKNTSVLETTQTNNFSNFDNLKKVYEQALKLWNDNYTKNGPFN
QLSINYQKYQALFETLAIINYLLDFKDGKPTYQNLINYLLKKTANHQPLF
IGWKALNDVTKIPNFGKDSKEDFSFKKYQINLYNGLDLYQLKKADVYEID
QNSQEVKFKKTFIDALTYTNDKNYWNSTVNKDGSVYNNFIGLIDQNNQKD
KLGKAFEKIDLFDKLVYANNPSKQFKGALYGYGSRELLIKTLDGFVSYHD
YQTLAQLLYDLNFNAEANAEFKTILDNQKQIIPGNQKDSKIKNIDLATNE
IKTIMIKGINKIPQTAFQRLDLDLVYNKLDKNATPLVNKEDNANLKYILL
VSQFNANDVQNLVINNQLNQSATGYLGLSKSQFYNLLFDLALNDQTLKIE
AFSQIENEHKIKVYDKRLANNSNLKGWIINNL
>UU437 conserved hypothetical
MHLDIDAFYATVSELLHPEYKNFPIAVGSLNSRTGIISSPNYLARSYGVK
AAMPIFLAKELCPNLIILPSEHNIYQSYSKHFFQIINKYTNKIEITSIDE
CFIDATDLVKKYHNNIRLLATKIQKEIKNKLNLSISIGISYNKTIAKMAT
ELNKPSGISIIDENKIINLIYELNINKIPYIGEIKSQELYAINIFKIKEL
IATENKQKISLVLGSIYQNLVNDLKGLSKIKIIDEDIYKTISHSKTFNED
LNDFYEISNEMNDLILTVTNRLKKCNLMTNNISIYIKYPSFKTKIKQKQL
TYYTDDYQTIFLAIKNLFKIMYKDETIRLIGISLNKLVKKENVKKQLFLF
D
>UU224 unique hypothetical membrane lipoprotein
MKKNHKKWLLMTTPILLIGGLSTLALTSCKDGKKSNPKPDKPSTIEEYKL
SLSSVETGFNEAKLIFDNNDSFKTLDNFKVILKNTQNTNEVIEASNLSAT
IENQKLVLKLNNLQDGQTYKINKILYQTNKEVILSNNQVFTTKTKPKIEY
EVQEKILKLDDKTYYVVLKVKDPQNLNEPTKEILKSVTFTSKISNVANLK
NAILENQRPYVKEDYSEIQIKLPRVPVISEKIEITANNSLFKSFTITVGE
KHIKNVEKIIDITKKVFGNQELKSISITKQNSSSANITLSLKLNGNSIIV
GANKLINKKDKAIKFSFFVKNKATNTVKEFNFNEKSKPIGSYQFTLNGLD
ANSDFVIEDIRYDDKSIKITEELLASLSFSTK
>UU419 conserved hypothetical
MPFIKTPNKDFGLVDNQIVLSSDYKKRYQRYFAKITGSRLGSILNIGDFT
NPVRTWAMMVKIYNEPIDPIYAQAGVVIEPKIKDYVETVLKVKYKQYEPA
QIGYDVFKDNQIFGGIPDGEPIDENGQLLYPNQPMLEIKTTSIDSFSFKT
IDYVLVLQKDEHNHPIIKKKGDKRAKWFNNDESEVIISDEYQLQLGLYCY
LRKISKGIFAIAFLTSEDYINPQAFDINKNEIILVNYELDLNEFEKVISK
AKTWYEEYIIKGISPKLTKEDLEWYKVWINKYETNNLY
>UU591 unique hypothetical
MIPLNYLTHYFSLKYKGDWSKIYLALINHEDQNEYLFLEKEDYEKVKAID
LTDEKYPNKYKKINQPPFILYYSTTVEWLDKKNIWLIDYENAISNYDILT
LIKAGYGFVIYYDSVVLDTLINRLISLKARICIITDEGIYSSKNIKYLSY
CNVSVISEIPKDYNSNKITQDLKRLACASSDHILCVNELYQIDDYLFNKY
KDCQLDLVLLDKKLAKQNTIYPKYINRIYQFIKNSKLIN
>UU408 unique hypothetical
MSKIVDNIDINALRINHYEEWEQNHIIKVINAYRHHESKKEKFKMIHELI
KNHQMHLTKLIPLFDVSISGYYKWLEDLKIDQVCPIKKRNMDLIEKICKS
HKHYIGCRKIQKILETQYNVKLNYKTINLYMNKMDLCKPCHHEHHEKKE
>UU336 unique hypothetical
MNKTNQIVDLLTNKQNNSIQRRDNLVFVKNEQEFKDILDSTISLSNVYDP
LLGNGCEQEKIKELTILNNSVDISKIEEYTKTLESKVDDLYNNVSNQLIQ
DYQKNENTSANNIIMKNEELLNSHLKEVEKICEQLIDEWKIEILGEVNFK
FQQQLIEIDQKQEHKLKVKSLINEDSFLTKRQVKNKNKILTEFEKHRSQI
TQNYLNKRSDILKKEYDELLKDDKLFELSSGDNWNNFKKITLFISNEIGI
INDLEDLLNHQELIRTRNYTKRAILNQHHINGHFKDEKKYLKSLYDLRVK
FMYGLGSEIVILKFLIEHYKKLNSLRLRLETLNHPLSNYAVYFDILNRIE
KQTQLLAKIETLKYDNYDFNADVILDDLESNITKINEIKHNSNVLNKTKV
IKTIIEPKYELELISKDDKVDGVKVYVNDQEILSK
>UU443 unique hypothetical membrane lipoprotein
MKHKKYKWIWLKLSMISAIPLLATIITACAKVDTKQKAKEELQSSLNKAV
LLKEIVDQSSYEDFKKIYNQTLKSNLENINKLSEQKLKQEQQTIKNLITQ
VSVLNELDSIKNMSDLIDVVELENTKKQLQDFLNQYEKLLNQASVDTTII
DKLKSDAHQKRLHTKALIQKTILDLANKIKNLIKTSGSNKNIVEIESDIQ
KLVNNNTKANFKKLYEDFKLIYTKLNDINDLINKELKALPFIKKLDDIVN
VINTIYQQNYSFLWFDQLKLTNLKQNLNKNITNIVNVKKSLDIEQIKSLT
NKLLNDLQNYLQGLNTIALDSENSINKLISIIQSLKPDDYNPYYSIEKQQ
NIQKDKNNSSKATYNGLENQIENLQSIISLFSFNTNSLTIDSANNLNNEL
TKKFEDANTKISSIVDQIKQTILSNFKKTYLFKDFIKHLKEFNTKVNSEN
DQAKKTNKTQTIQDVLNSYKNDPWINTKVSLKLSANQTLTIDNLENIDLA
YSNDFLLKPKELINYLKLDNNQERVFTKDIENFSVKIFTIVDKKLYIPEA
KELIEESKKITETKNGKTNNESKVERLKKFTKFVEQGINNNNVSSYTLDL
YNKKLKKLIEEVKKIQNGTSQKIENNSK
>UU370 conserved hypothetical
MRKLALDLGTKSCGFAISDLLGIIASGLDNFIYEENDFTAVLAKIDEIMI
NYHHEIDTIVLGYPTNVYDGSKNERTYLIESFYALLKQHFLNHEKIKIVY
EDERFSTKIATQRLKNSCVKAAKIKKVKDKMSAVVILESYLSKNHFN
>UU028 ABCsbp-3, putative ABC substrate-binding protein-iron
MKIKLKKIIMSFLGLPILAIPLIVSACSQFKINQDVILTYRPTVSLAKEF
ANDNNTIDDVLKKVKINKDGSNNLLVYDLSRNPKNVQYKIVDIKKDSEQI
LKVTINAKIQKYKESINYDFYFQPFLTPKQKEDKTILQQNLNIIKSAWDY
DQKQKIGFFNLRIKPEYQKRSLVEIKTLGEKAFNFGEDLIPQLKVDSKFK
DINIKIIDINYFEPLDERQRELVVEIMISKGKNEQQAQLFKKIKINLD
>UU529 codV, integrase-recombinase protein
MKKFINYLKNVKGYSDGTIAIYQKYVKVLIDNNLDYLKAIKKYEHNANVT
KRVVLSAFKAYLKFINHKDAILIVMPKKEIKVKEFLTWDNFLKIINNINQ
ATFLGFQKYLILRILFETGIRSCELLKLEIKDIYENKLKIHGKGKKERFV
YLSNDLQNNIKKYIGQIKTKYLFNFSYKNLYQKVTRIKTNIRLTPHILRR
SFANHCINNGINIYDLSLVMGHNNINSTSLYLNKESKLVELDHLFDNKKV
N
>UU528 dcm, cytosine-specific methyltransferase
MTGEQLIKSVGNKGIDLLTYSFPCQDLSTAGSFSKKAFGMKKGSGTRSGL
LWEIERILFDLQKLNQLPQFLLLENVNNMLSKQHKLDYDMWTKSLKQLGY
STCTFQLNALDYGSAQRRKRVYAISILNYDGLIDSNGNILDLEAPIFDGK
QKQLKDVLKTNYKIEKYYQEAYLAQPNRTFSRIKYVIPKYDLLNPNCYCT
STITTRQDRFPNGGYINLKNTILGDDYREKDHNNLPKKANFRLLTNREAY
LLMGFNEKDFEAIQAKGISKAKMYQQAGNSIVVDVMVYLMKLIQERFNK
>UU582 deaD, ATP-dependent RNA helicase
MKFNSNYQKWILDSLINQKIFEPTPIQLKTMPLIAKRENIIGVAPTGTGK
TLAFVLPILNNLDLSQKLQVIIITPTRELARQIFSKIIVFKKHQPLLQVK
MLIGGESIDQQINSQLNKSQLLIATPTRLKQILTRQILDLHHVNALVFDE
ADMLMDLGFISDLEFINSQFTNKDVQKISFSATLHEMLSIQLKKYFKNTK
IINISNSIYENKKITHYVIHNHDKWHSLSIIMKTIKPYLCIIFANTKKEV
EAIYQYLIQQNKNVCILHGSLLQRERKNNYRDIKNNKFQYVVASDIASRG
LDIDGVSHIINWNLPTENEWYIHRAGRSGRGKYSGESYVLYDQKEHDKLL
NLSKKGIVFHHKFIKENELFDKEFLFKKKNQFKDLKTQNEIQKIISTTST
KIKPGYKKKIKEAIQKINQKNKRSHIEKKMNAHRIRGYKLKNS
>UU001 dnaA, chromosomal replication initiator protein
MANNYQTLYDSAIKRIPYDLISDQAYAILQNAKTHKVCDGVLYIIVANAF
EKSIINGNFINIISKYLSEEFKKENIVNFEFIIDNEKLLINSNFLIKETN
IKNRFNFSDELLRYNFNNLVISNFNQKAIKAIENLFSNNYDNSSMCNPLF
LFGKVGVGKTHIVAAAGNRFANSNPNLKIYYYEGQDFFRKFCSASLKGTS
YVEEFKKEIASADLLIFEDIQNIQSRDSTAELFFNIFNDIKLNGGKIILT
SDRTPNELNGFHNRIISRLASGLQCKISQPDKNEAIKIINNWFEFKKKYQ
ITDEAKEYIAEGFHTDIRQMIGNLKQICFWADNDTNKDLIITKDYVIECS
VENEIPLNIVVKKQFKPEQIIEIVAKELNIKTDLIKSSIRKNNIVWARDI
VCYILKNKLNLTLTDIGKLLNGREHTTISHSISKVQKILDDENSQEALQI
NLIINKF
>UU550 dnaB, replicative DNA helicase
MPTKDLNDAILDLFCLIINNNDFWKDVVLRLEVKDFPEKIQQNIFNTIAN
LNEQKYKINESNILNALANYVIIDEQDQNYLLHKNYLLQILDRTDYLVDL
KDCIEIIKNASIKNKLDVFANEILATQISLINAKDQFKEMHEKFLEILAS
RTEDTIENMELIANRYFEKLNKIGNSGIIPGVIKTKYDNIDKFTNGYKPG
ELVVIAARPGIGKTTFCLNVMVNNVNEIIEYNENIQPNQKEKIIVMFSLE
ITKEQILQKFISIKTGISNREVIENKYRITKGYDTRSFAMQAINDIKSWP
IFIDDRPNISIVDIEAKLYDLKKRYDIALVVLDYLQLVSGGNANKNMTRT
QEVGRVSSALKIIAKEINAPVIAIAQLSRKAEERDVSNNVNMKNNPLVKT
IDNSPKLSDLRESGSIEQDADVVAFLHWDRKQRNFMQNDNQETRMRDDLI
EAKFIVEKNRNGSTGETDIIFSKLNSKFIRATTSKE
>UU415 dnaE, DNA polymerase III alpha chain 2
MFINLNVHSHYSLLNSTLSIDDLIKYALDNKQPYVCLTDLNNMYGCIEFY
DKAKAHNLTPIIGLEFEYQNATLVAYAKNYNGYLKLIKWSSWIMTSKEFE
IQDDFDDLIIVCKKGTIVFKSPNFYQTHDQNAPNAIALQSVFYANKNDKI
VFLAMLAIKNDLKLEDFKNCCDFDNNHFLNDNLAQSFFSPIALNNLNKVL
NELKVQIHDLPINIPVYDKQNSIISSEILKQLCISGLKKRLNANDGQVNK
IYVQRLKYELDVINEKQFDDYFLIVYDFINFAKSNGIIVGPGRGSAAGSL
VAYCLHITDIDPIKHNLIFERFLNPTRKSMPDIDTDIMDEKRDLVIEYLF
EKYGNDHVAYILTFQRLKAKMAIRDVGRILGIDLKVIDKICKNIKPEYDE
DLDLAIKKNTILKEMYLLHKELFEISKKLINAPRQIGTHAAGIILSDSLI
SNIIPIQLGINDRPLSQYSMEYLERFGLIKMDLLGLKNLTIIDNVLKMIY
ENQNKKIDLFNINYNDKFVFEDLAKARTNGIFQLESPGMKKVLLKVKPQN
IEDISIVSALFRPGPQQNIKTFVERRFKREEFSYWNEATRKILEPTYGII
VYQEQVIELVKTIANFDIATSDNFRRAISKKDEKILIQLKDDFINGALNN
NYKQPLVNQIFEYIFSFAHYGFNHSHSLAYSYISYWLAYLKHYYTLEFLS
VLLSHTSASKDKLLSYLNEAKEFNISIKGPDIQYFSNDFVIDTQKQIIRF
GFKTIKGFGDELLKKIKSALQKSTLSDYISYIDALKKGNVSLKNIEILIR
VGTFDSFGINRLFLLNNLNEIFEKTGLNGHFFDLNLVGLDYAKDMSVNDR
YLDDEIQYLGIDLNSLNYANYKTEIDYNKLKYTIKDFYEINTNYETNILA
QVLNIKQSKTKNGNDIFYLETLIDNKKQTLTIFQNSKYLIDEISIGGIYV
FGVKLLNHFNFIVNIKQRI
>UU494 dnaG, DNA primase
MSKITNNVFLTIRNAINISDVIQNYIKVIKKGNNYWAICPFHNDTNESLS
INDKKQIFKCFACNHAGDVIKFVAEYKKISYALAAQEIVQLMNLDLNLLN
HLQKISPQEIKKNKVFDLNKQIQKWFINFLNNKNNIHVIDYLTKRNLNKN
DLAYFKIGYAPNNDELLNLIKSNYNNLIQENDEFELNKLIENSFLVIDKN
GNYHDFFNDRIIFSIYDHLNNVVGFSGRIITNEKTPKYLNTKTTAVFKKD
EVLYNFHNVITIENNHQLFIVEGFMDVITIHKSNKPNVVATMGVELTNKH
LELIKSYGIKDLILCFDNDQAGFLATKKQIMKLINSPFNIFIVNHKDNDC
KDMDEYANKHGYSATSKLLDQQLHISEFLLLEISNTNKSTPSLKHSYKQE
CFTIIKKYGDIFYVDKYVDFMKQTFSIEENLLKKVIEELLINKQCNSIQN
KKNIQSYQKQTQLTNKLTTSNPKVILTKIDKHFNHLVVIILMNRVFLNRL
DTQVRNRLTKEQSLVINIIEDFYLYHFKINNILKNTDSFIEFINKNYSKY
TNVINQLTKMVQIIKYNPKFDNIVAFELAKNNFIYEWLNNQIKRLKLINL
NLNMNNNQEQIINNEKLIKQYNDEKILLDNLINASLFHKNQ
>UU019 dnaH, DNA polymerase III delta subunit
MKYSFANLLIQSPKTSLESGIEEIMLAFIYEKNHKEQSFYVTKVKNKQYF
DLKIYDGLSMKKSDVIDLQNTFLCDGVEDINLKFYLIKNIDLASKYVLNA
LLKFIEEPPKNTIAIFSTKNLNQVLKTIKSRCQLFYLPTNHDLYKKLINQ
INQPIDLVECDLMFDDLDELKILLENKEINDVLTYYGKLSDLRSFEILND
LKEIFKNLSTLQIHYLLKLIFIRINNVNSKEIILDLMRANLKININKNNL
FTIIYTIINKNKGD
>UU079 dnaN, DNA pol III beta chain
MEVFISIKKLIEAIKFSTTIANTNNANALLLGVLIEVSQNKISFKTTNNQ
VSGYKEITEGFEYFNSGKVLVTAKIILGLISKLKDKSVLLKQIDTNILLI
KTENFETQINTMNIEGFPNLNFSLEDYVKISLPHQIMQEINTKVLPNVLN
SQGIEKIQPISGILIDTQTLENKLIAIGTDKIKASCLIREYMGEKFKFIV
SYSTMKLIIEILKNVEYSNNQTVDFYVRSRSLIFKINDAILQTRMIDGVY
PNIYSIFDETNEENTYVFDRRLLIEIIERGMNIVMQEQNPKISIRIDKNE
AEISLTTFEIGNMKEKMSIVNLNNKSAEFILNPSLLAHVLKNFDNNDVTF
KVKDEILRPIIFIDTKDVGFKQILSRIKN
>UU087 dnaX, DNA polymerase III gamma-tau subunits
MSESTLYRKYRPHKFKNVIGQDLIKQALMNACLNNKITHAYIFSGPRGIG
KTSIARIFASSINCLNPNKGDCCGKCSVCESILKEQSVDLIELDAASNNG
VDQIRIITDNINYLPTFFKYKVYIIDEAHMLSTSAWNALLKTVEEPPQHV
IFIFATTEYQKIPLTIISRCQRYDFKRLNNSELQELIDSILTKEDIKIDN
NAIDKLIQLADGSGRDCLSILDQLTTVKKNIDLDLINKTFGLVDNFKVIS
LIELIQKNDILLLREFIYELYNQGVNLEAFCVQIINVLIDYLIYLKTNDI
NNLKKVSVDELKKMLLINFNGNYLLNNFISLFNNLKKSLNQVFEFEIYLY
KIINANNDKLENKKIELSINPEENKINNSQIITTKKIDCFEEINKNTVDF
DKLYKTKIFYHKKINNQNDKESGINQKEELSTELVNDNKLICNSNDILDN
YELAKQAFFNKDIKLSKEMSQKFKDFKNEETIENSYIDIIKQADLVLWCS
PNALVLGVEFLGLINRINKVTHSFEFIKEFVKKFDSIKLVIAISKKQALN
IINIKKQGLKTNIINDVLIDDIKMLLKQEEQRKQEQTALLNEIEDEE
>UU413 fpg, formamidopyrimidine-DNA glycosylase
MPELPEVQTIVDYLNHHVLDIFIKKTIVHLPKILKNKTPQEFEKLLINHK
IVKIKRLGKYLLFFLSNNLVLSVHLRMEGKFYYQAKEEWFNLAHTHIIIE
FNNGMQLRYNDTRQFGTFHIYEQQSFLDSKELKKIALDPLDNNFSAQYLY
EKLKKSNKAIKTALLDQSVVSGIGNIYADEILFAAKIFPTILAKNLTLKN
YEKITKEAQRILLLSIKNKGTTIHTYKFGNDETGLFQKMLLVHTHAKEPC
QICGTIIQKTKVNGRGTYYCPNCQN
>UU082 gyrA, DNA topoisomerase chain A-DNA gyrase A subunit
MALKKPKKSRLTTEEIKQQLEGSTIKEQSITKEVETSFLDYSMSVIVARA
LPDVRDGFKPVHRRALFAAFENGMTHDKPYKKSARWVGDVIGKYHPHGDQ
AVYQTIVRMAQDFSMRYLLVDGHGNFGSIDGDSAAAMRYTEARLSKISYE
LLKYIDKETVDFVPNYDASEQEPSVLPSGFPNLLTNGTTGIAVGMATNIP
PHNLTEVCQAIKAYAKNHNVTISEIMEYLKGPDFPTGAEIYGDSGIIKYF
NTGRGSVTIRSKYEIEDIGQGRVAIVVTEIPYMVNKANLIEKIVELVTNK
QIEGISDLRDESSRDGIRIVIEVKRDVIPEVLLNKLFKTTPLQTNFSVNN
LALVNGVPMVLNIKEMIKYYFEHQIEILVRRTNFDLKKAKERIHIVEGLV
IAVNNIDEVIKIIKASGDDDIASKSLIQRFDLTELQTKAILEMRLRALTG
LNIDKLKKEYEDLILVIKDLEDVLNNYNRQVNIICENLDYLIEKFGDERR
TEIMYGVSSHIDDEDLIPVEDIVVTMSKRGYFKRLPIDTYKNQRRGGVGV
QGLKTYEDDDVEKILVANTHTDLLFFSDLGRVYRLRGHEVPLGSRQSKGI
PAINFLPIEKSESILTILPIDNYDQGSLFFTTSKGIIKRANLSDFESIRA
NGKIAITLKDGDKLFSVMQTLGNDEVFIGASNGNVIRFNENDAREMGRIA
TGVKGINLENDEYVVGTGLSSHGEYVLAVGSKGLGKLTDINDYRLTKRGA
KGVNTLKVNDKTGNLVSIKVVNREEEALIITTSGKVIRLSIKDISVIGRN
TSGVKLISLENKEEVKSIAIFKKEEINDEQLLQENDYNLK
>UU081 gyrB, DNA topoisomerase-DNA gyrase subunit B
MNDSNKEKKYTAESIKVLEGLEAVRKRPGMYIGSTQSEGLHHMIWEIVDN
SIDEAMGGFATIVRVILKKDGSVRVEDDGRGIPIEIHEKTGLSGVETVLT
VLHAGGKFDNDSYKVSGGLHGVGASVVNALSKNFKVWVNKNHVQYYVEFI
NGGHAIEPLKPINNKDVKEKGTTIEFIPDFEIMEENEWDELKIMARLKQL
AYLNKGVNIEFESELTNRKEKWHYEGGLKEYITDLNAEKEPLFDLIVYGE
EEKEVRVPGHNEQTYNIKCEVAFQYNNSYNNSTHSFCNNINTTEGGTHEE
GFKLAITRLLNKYAVDKKYLKDTDDKITKEDVSEGLTAIISVKHPNPQYE
GQTKKKLGNSEVRPYVNEITSIIFEKFLNENPEESKKIVAKVMQAAEARR
RSHEAREATRRKSPFESNSLPGKLADCSNRDSSVTEIYIVEGDSAGGSAK
TGREREFQAILPLRGKIINVEKAKIDKIFANEEIQNMITAFGAGIGPEFN
IEKLRYSKIIIMTDADVDGSHIRILLLTFFYRYMLPLIQNGNVYIAQPPL
YKVSYAKTIKYAYSDQELERIKSTISNIKYNIQRYKGLGEMNPDQLWETT
MDPKNRLLLKVNIEDAAIADKTFSLLMGDDVAPRKEFIEKNAKYVKNIDA
>UU282 hupA, DNA-binding protein Hu-alpha (HU-2)
MNAKIKAKTRSQMIDELSKMLNIEKKQTKAFMDTYEAFLILELSRAKEVR
LGNIGKFKVSVRAERKGINPKTGETVIIPEKTIPKFTFTKGIKEIINAGI
SIDNERVSIDDNDFDDDDEFVEEYIVSENN
>UU121 lig, DNA ligase
MDKIKAKIDELKQKLDQWNYEYYVLDDPSVPDHVYDQTMRELIELENNYP
QFKTNNSPSVKVGGFVSEKFNKVKHKRPMLSLSNAFNDDDLKKFDQDNQN
ASVDLKGYVVEPKIDGLSISIIYKNAKLHQAITRGDGINGEDVTSNILTI
KDIPHYIDQKYKDYEIEVRGEVYMAFHDFYEMNDNLEESDKKFANPRNAA
AGTLRSLDNSIVAERKLSAFMYYLVNAQELGIKTHYESIQFLRDNKFKVS
DLIVKVDTINEVINQIDCYTKVRDKLSYMIDGIVIKINNLEVYDEIGYTS
KFPKWAIAYKFPANVVSSQLLEIINDVGRTGKISYVAKIKPILLDGSMVE
YATLHNFDFIKEKDIRINDEIKIYKAGDVIPYVDGVDLSKRLANSVPYEP
IINCPSCQSVLVRENDEVDQRCLNIYGCKKINIEKIVYFVSRNCMNIEGM
SDAIINKFYDANLIKNIADLYYLQKHKEFILTSDFKIKEKSFSNLINSIN
NSKKCSLEFLLTAFGIRHVGPNLAKKIAKQFKTMTALMHANFDELTNVDA
CGEKAALSLINWFNDEHNVSLVNQLQQVGVNMEYIDDFIYDDNINIIDEY
KNKTFVITGSFSISRDEIKTILEKYYHAKVKNSVSKKTDYVLVGTEAGTK
LEKAKLLGVKIIENEFWKKDNNF
>UU055 mnuA-1, membrane nuclease A-hypothetical
MVCKKNKLKMFGFIAIGTVLTSAIIPFLVTCAKEKKIKQEVIKPKQISNL
NLEAKNIDIVLKNNVFNKETAKFTLDFDINKELNLQMVAVFDVFDKKNNW
LKTIKTAKTNLVDKKFVFDSLDENVKYLLKQIDFYDPKAPNQIIYTKNNQ
TFSFDTKMDDSIARTVELIIISGFNGFVDEQIVPDYNKQTTYLKAPGLIR
LLNEVNKIKKERGANNVAVVMGGNNYYENNISSLTRAQYTTAALKFLNPV
ATSIANTDLNWGYDLIDEKTKHFKEYVKALYGNDGILSVNSYLKDGDKNI
QMTNNSKIINFGGFKLGLIGAMSNLINFESNLNLTKNIQWFSNEQTANLI
NDEADKLKDQGVKNIVLLSSFLADKAKENDTLTNDEKSFYKEASRMSKLI
DNNVNLMSVINPYKALNVIANNKNNQPLNVVQSKPNSGFVRYMITLNPYN
RILKTEIKLVDKLSTSGDNAGYHYITQQDLLNPQKNPDFNQNLITLNNFL
NNYKDHEYEQLREKILIKNDKKVNLYSSTYSLSSLGAFISDILAKYYQAP
FYNKQTHTFEFKQTQAILLAPHAIRSLVSAKPIKLENLNQILPFNDTLVS
GEISVKNLKEFLINKNKSQNYNEPYQFSNTLKIEYENLQETKTKKKSRKK
QSEQSYSDNEKKDGLILSHQKRVIKVFLKNSDGTYTELNDNQKIIVSVMN
SILKFNKKFSEALLNKTYADQTNIRDLLRTYLPKETQIDQKYDQSVFSKN
DARFYKKKETDQNKSLIYNHINESINNKQADHLRIGHWNVLHQTGLNDPK
NYALAKTILFNKYDIIGLTEIWPAENNNQEQNNLPLIGIIKYLNQLSGSD
DYDFLISDNLKGSENDKLATNEHTSTERIGIIYNKKKVKPIPFANNKIGY
IYSNPLQPGKYEKAETDYSRPPFAIKFASIGQIKNDFTLVFGHLDSPGTY
PSNTEYQKKEHLLKRTELVNKKVISTNQMINKYEQGSREVDDAERLVKVM
EEIKKIDNNKDDDYFFLGDTNIRLHNQQWVFRTLIQNGYSSVFSDNDLFK
SSLSVNPGEFSNPYDKIFSQVNGLTISNPSIYNLWNVYEDQIVDQEWLKK
VRSLYPNEYHDKLFYIRNDISDHAPTFFDLGLNKNDTK
>UU477 mod, adenine specific DNA methyltransferase
MMNERLKLAKNLLKNDGVIFVSIDDNEQAYLKVLMDEIFGEENFVTNFIW
QKKSGGGLNKLIYEGHEYILCYSKNNYNFCLSEKNKKMSGFIKYKDKNNN
SFFINSDIIRNNFGKKDNKFEHRNKAYEDLSKEDKEKWNLKLDNKNYILV
PFKKEPGKHLVAKIFNDERKTTYSIIKLPFTFVSGIWTKDGNNEVDSLNI
DFQNPKPIQLIMHLLDLHSNKNARVLDFFAGSGTTGHAVLELNKEDGGNR
TFTLITNNENQIGTNVCYERLYRINNGIGTKNEIDFDWVSKNKPYLNKLN
VYDLKYFDTNPIEVDNSKIKKVFAKMLVDFNNTSQSSLFENNQRELLINL
STLKPIEKKE
>UU306 nfo, endonuclease IV
MDKYNLIIGSHVSLKAKDFFYGSVKEALSYGSNTFMVYTGAPQNTKRQPI
KSFKIEEAHNLLKKHNINLDDLIVHAPYIINPCSSKKNVRELAKEFLIQE
IQRTESMGITKLVLHPGSRLEQNEDIALEQVYTMLNDIFSTINTNVIVCL
ETMAGKGSEIGVNIKQLKTIIDNVHSKKNIGVCLDTCHMNDSGLILDYYN
FNQYLKEFDAQIGINYIKVLHINDSKNPCGANKDRHENLGYGTIGFANLI
NIIYHPLLNNIPKILETPWFNVNDELIPLYKHEIKMIRDCKWYDIKNKLL
SKK
>UU467 parC/gyrA, topoisomerase IV subunit A
MSVNHQKIINTPLDNIVGESYAKYAKYIIQDRALPDIRDGLKPVQRRILY
AMSELGIFYDKPYKKSARTVGEVIGKYHPHGDSSIYEAMVRMSQDWKNNL
CLLDMHGNKGSIDGDNAAAMRYTEARLSKIASVMLANLKKDVVKFSPNFD
DSEKEPSILPSLFPNLLINGATGIASGYATNIPPHNPNEVFDALIYRIDH
PDCSVEKLIEICPAPDFPTGGEIHDLNGCANAHKTGEGKFIIRACIDFKI
NDNKINQIIISSIPYETNKALIIKEIEDIIYNKEVAGLIEVRDESDAKGI
SIIIDTKKDINLENVKNYLYKKTNLEISYNTKFIAIVHRTPTLVNLSTYL
DAQINHSLDVINKVDLYDLNKILLRIEIVEGLIKCVDLIDEIIKIIRASE
SRQDAKNTLIQVFNFTNNQAEAIIMMRLHNLTRTDIFDLKNEWQTLQDEA
KTLQERINSLQVRKNYLKQKMIEFKKTFGFERKTKLFDELVKVEINEDQM
IEKQNLNLVISRDGYIKTVSKKSFESSKYDELGLKTNDILFYHNIINSHD
KILIITSKAKLINLVAHKITSMRWKDVGEHLNNYVKFDANEKVIAVYIWN
EQFKIDEYQLVLASRLNLIKRIELSELDINKNSKQISIMKLNDNDNLISA
NLIKKGHNQFIIAISKLGLALLFLVHEINCLNRLAKGIKIMKLKPNDEVS
AILITPNNGYNVQLFLERGSKCFNISELKLSKRAATPTNLYPITKKVQNV
LAAFLVAHENVFYLLDQQQKINPYYLSNPKPTKLDTKISIYENDQMITDV
VKDCFLSDEAISDFKKINMYANEFDNEMLKINKNHDDSQLELIDEEEEKK
>UU466 parE/gyrB, topoisomerase IV subunit B
MANKYDGNAIKILEGLEAVRKRPGMYIGSTSSTGLHHLIWEIVDNSIDEV
MNANAKNINVILHEDNSISVLDDGRGIPVDINSQTKISTVETVLTVLHAG
GKFDESAYKTAGGLHGVGSSVVNALSSWLICEVYRDQKIYQAKFINGGHI
NQSLKVIGTTKKTGTLIHFLPDPLIFKNLVFNPNIIKERLHESTFLIKDL
KIIFEDKINKKKYEFINNQGLIDFIKFINEAKKTFSDVIYFRSNINKIDV
EIAFQYSDQNNEIMVSFANSVKTSEGGVHENAFKNALTSVVNNYARKHNL
LKEKDKNLEGDDIREGLSSVISLRIPESLISYEGQTKNKLFTPEANEAVK
KTIEDNFSFWLEENKTQALDLVNRAILARDAKLAAKRAREETKKVKKIKE
ERGMGGKLTPAQSKDPVLNELFLVEGDSAGGSAKLGRNKKYQAILPLRGK
VLNVLKARLVDVLKNEEIASIFTCLGTGIGAEFDLKKLKYHKIIIMTDAD
TDGSHIQVLLLTLFYRFMRPLIENGNIYIALPPLYKLTNKNNKKFFYAWD
DVELDQLKKEQKNYEIQRYKGLGEMNADQLFETTMDPNNRLLLKININDI
LQAERQINTLMGNDVSIRKQWIDNNIDFSVIDELQINNEESK
>UU216 pkn, serine/threonine kinase
MREEIKTNSILNYKYKVVKHLADGGFSKVYLCCFLSDETKFIVIKVLDIN
DEKQQMVVYDELRISNLIKNSDSDKKNYIMEYYEYFETGSLENNDKRIYI
VFEYIEGLTLREYLDEFKTITYVKAVEIIRQVALGVSFFHSCNPQIIHRD
LKPENCMINKTLTKIKIIDYGAASVFYNREDLTKDQEIKCTIIYASPKLL
SLGQKVKEQANKGLNKRALSLINDALGVSYDIHSLGVMLYELITGTNPFS
EHTITDDRDYLEKWITYDVEPLSLINKTIPKGIDNILMRCFAWKKEDNKL
LYKDIYTLIDDLSNVMDPESNLNQEYIKPLNKLRIYRKNLAGLYEIKEKD
RKWYLQKWFIILISCLSVILIILLIIILFFKKSGAI
>UU414 polA, DNA polymerase I: 5'-3' exonuclease domain
MKKAIVIDGNSLIYRAFHATYKQAEWAVEKQLMPTNAIKLVASMIFKILN
QEQFTYGLIAMDASKQTFRAQEYAAYKATRKPMDAKLIVQLPYLKKLFVA
MGFRIISQPGIEADDFVGSFSNLMNKFDVDTTIYSSDRDMLQLINKNTKL
KLLKTGTSVMQEINLTNFSLLNNGILPYQIIEYKGLVGDSSDNLIGVKGI
GPKTAINLLLKYDNIENIYTNLEKIAPSVKNKLIEHKDMAFLSKKLAAIQ
TDLLFDEKLENFVLKPYNTQELDELFTSLKINNMQNYYK
>UU377 polC, DNA polymerase III alpha chain 1
METKNALFKKIVKISDQLLNKISIKKLTKDKKNNLFVYFDEFVDVTIIDE
LHQLSKTTLMHDLQIWYINNLKEVDHKKILTFFKKISEQNANLIFLEQIN
DLNTKIEYNSNLNSLILKINDKLIYDHFIANKLEILNILKVWSLPYSNFE
IHFENLSSLLNEKHEQAVNEIISHHIQQQKHLEQQISQQQNFYNNQKANF
NYYKNPSNKTITKLIDINPLMNNAKIRAYVFLKKIDILKSGAIAYKLNVI
DDSETLTIMTYLPSGEHPLKKFLDELKIDQLIEAEIDIVLDNMSKSGQVP
IGKIKKICCVEDKHVKKQITPRLELNFHTKMSSLDAIISTQELIDFAVKN
QLKTIGITDRNVVQAYPEIAKFSKKQDLKIIYGLETEELEDQIPLVLNVR
DQNLDNATYVIFDIETTGLFPNFDEIIEFGAVIMQNNKQIGEKIQFFIKP
IQQINENVTNLTNISQEMVNNAIDEKTALLKIKEIFDDHILVAHNGINFD
INFINQRLLKWGLEPLKNPSIDTLMISRAINPFKSHRLGAICKKYEVDYN
DESAHRADYDAIVLADVFKVMKNNLFNDFGITNLSEINTKLQTTMLKNRS
FGNWINLYIKNQANVKDMYELVSISHTDMYYTRPTITTSFLANKKDKLII
SNSIHESDLINALYSKNDEEIKRLIQRYDFITLPSLGSQKHLVYAKKITI
ENVQKAFKKLIYLALELNKIIIYSSSPYYFFKDDKKFYDVYVNTKGLEGK
AHRFANEVYVPDLEYIDQKNAIDELAYLEDEKLINLIINENPVHINSWFD
DSIQPLKEGLYAPKMEGVDQKTIDYVYHTAKKIYGENLPTIVEQRIKKEL
NSIIKHGFSVVYWISHLLVEKSMQDGYGVGSRGSVGSSLVATFLNITDVN
PLTPHYLCPNCKKCEFITNADDGFDLAPKSCEQCQTPMLTDGHNIPFETF
LGFDGDKVPDIDLNFSGVYQAVAHNFIKSIFGETHSYRAGTIGTMAQTSA
ENTVKKYFENRFNENKIIRDSTVSLYVQKCIDSKRTTGQHPGGIIIVPKE
YSIWDFSPYNFPANDINETWKTTHFAFEYLHDSLLKFDILGHDNPTILKL
LKDYTGIDERDVPMYDPLVMKSFSDISALNIKPSDVLNETTGAISIPEFG
TRFVRGMLVDTKPKSFADLIRISGLSHGESVWLGNAQSLIKSGKLLKDVI
ACRDDIMTYLIRQNVEPKTAFLIMEDVRKGKKIKPEHQIILKELKVPEWY
IESANKIKYMFPKAHATAYVMHAWKFAWYKIYYPLEYYAAFFSVRADNFD
LFVINQGKEFIEKTYNDIEQRSKSRDPQKKVSSRELALQPIYEIVIELLA
RGFKISNISIEQSQATSYVIDKENNAIIPPFIAIQGLGETVANSIIEARN
QKVFSTIEDLKNRTKISRTDLKNLRVLGVLDHLSETEQLTLF
>UU084 recA, recombination protein
MKENNNLEKLDPIATLETKFAKSSYFIADEIKDEKINAISTGSIHIDQIT
GINGIPVGKITEIYGNESSGKTTIALQTIAECQKTGGTVVLLDLEGSFDI
NYAKSLKVDLTKLIITQPQTGEQAFDMIETLIKTNSIDLIVIDSVAAMLP
ESEYQANMNEALMGAHARLMSKGLRKIQPLINKSKTAIIFINQLREKINT
FFGNPEMTTGGKALKFYASLRIETKKADLIKEGINKIGIKTKVTTVKNKL
APPLQTCFIDIFFGSGFDYNNEIIDFAIQYGVLKKNGSWFYFNDNKIGQG
REQLKNTLSKNNELFIQISEKTLEFVNNEKSNWQ
>UU089 recR, recombinational DNA repair protein
MSKPVEFEMLVDALKSLPGVGTKNANKWAFFLLQQDQKYIDDLIKRIKEA
KTNILKCKYCANFTNKDECDICLNEYRDFTKLMIVTTNEDLERIESANIY
NGLYHITNGEISLRKNVVIEHTNIKTIKERVLNGSFKEIIIATSYTHDGE
VTADYIIRMLEDIKDLQIYRIGFGIPLNSSIDYADDETLKQSLINKRKIR
N
>UU145 ripX, integrase-recombinase protein
MERQSMINKFLQSIKKRNLSKNTYLTYESHLRKFKVQEQSFKQIIKQLLN
NNYKPKSLKLAKSILSEYWKFSKQYQYVQELEQIKLSKEQKSYKKVFSLD
DIKKCLKINKQDTKQIKFYKTILLFYATTGIRAMEIYQLKQINNDLFVIS
GKGNKNRQICYIEHLWNNIKNKKLPSTKTLRKYLKVFFDNKNVSLHTLRR
SFITNFLTSNENYKRGDMLKIVQDLVGHENIQTTLQYVQITKEQVDDVYK
EFFKEFENDK
>UU397 rnhB, ribonuclease HII
MAIVSVKLTSNQVDKFLILWRPYLVHNNHNYAKYTFKIDGTLIIIYNTNT
CTINTHDINSFLNTFLKREDLTLFNVIKQQVNTKKNNQNVMSQSEIYESA
QVIIGSDEVGVGDLFGGIVVCAVSLKKSDFKKINHLKIIDSKKLNDQQMQ
EIYQQIKNQISYTIVSYNPKEYNELIKEYNNAHILKTILHYKALQSEIHK
HAKYSIFSVVDAFSSLKNWNQYLQKVNFQPYEPNLLIPKAESIYTSVALA
SIIARVMFLKMIAIIEEQFNVKIPLGSSNPLVNDVASNIFQKFGLKILKQ
VAKEHFSNFQQIIKNK
>UU449 ruvA, holliday-junction binding protein
MNYLIFKVIYANANIVVGEHNFIGYQIRIPKDYELEINKFCKLYLYEYIS
IMPNKNLIIKDLYGFRTYNERLLFIDLISINSIGPKTAINILKYDIDTII
DAIATKNIDYLITIKGINQRNANLICDQLNYKYINKVNDKNNWAKELSIG
LENLGYTKKDIEYAITKVKINSQQDIDISEIISSAIKEISLRHEN
>UU438 ruvB-1, holliday junction DNA helicase (fragment)
MIANNAKGIPRLANRLLKRVVDFKINGFNDIKSIFKKIQIYEFGLDEQDI
NYLNVLYRQDNEIGLKSIAQILRLDQYTIETKIEPYLIQHHFINKNLRGR
KITIEGIDF
>UU448 ruvB-2, holliday junction DNA helicase
MKTNYEFRPQYLKDFIGKEQLKNNLKVYLTASKRLENSFDHTLLHGLSGT
GKTTLALIIANEMNVNCHITQGNLLNKPIDIINLLSLIKENDVVFIDEIH
ACGLGAFETLYSVLEDFCIDINIGKDFNSKMTRLKIPHFTLIGATTIFGK
IPKSLEERFGHIFHLNEYEPSEISAIILKNNQMHFQIDLNEEEIDLIANN
AKGIPRLANRLLKRVVDFKINGFNDIKNIFKKIQIYEFGLDEQDINYLNV
LYRQDNEIGLKSIAQILRLDQYTIETKIEPYLIQHHFINKNLRGRKITIE
GIDFLKNNQLIK
>UU553 ssb, single-strand binding protein
MNKVILIGNLVRDPEARQIPSGRLVTNFTIAVNDNTPNANANFIRCVAWN
NQANFLTTYLKKGDAIAIEGRIVSRSYVDNNGKTNYVTEVYADQVQSLSR
RNQSPSDNNKVNVDTMMESYTGINTDAAFSSNKPQTTLSSTTSNLNKNND
EEDEITSWINLDDDLE
>UU372 tnp-1, integrase-recombinase protein
MNKLGLLCEIRRSKRKREIKNVNATFKNLANRDYDGQMNDIYATDVTYIP
SPTDVIENHVYLSVLLHHKTKKIVSWNLSKYNDTNLVLKHFKLTKFPKKF
IVHSDHGYQYSSKEFLDYIDSINGTISMSRVGNSLDNREVEYFFSILKTE
IFSNFFQKAKSLTFNELQIEIDKFINLYNNERFIKKFDLKTPQQMWDVYM
NNKSIWV
>UU404 tnp-2, integrase-recombinase protein
MDKKNIFTILEKLVKKYKYLHKPILDDYISTFTRTFLEYILTIEMKYHLN
YERFERYLSSNSKNYRNGFSKKQLYMNDLKVSINIPRDRNGAFESKIISK
YQVDISHFEYRLLSLGINNLQLNEYEKILEDIYNIYNDKMVDKLCNEIAL
KIFDYLENKKQELNNIDVDQIFIDGFNLSSNKWLTIVITKDLEKRLTILG
FWVINNLEDKWWNDIIIKISKYHPQVINYKVIFKDNDELLMSLKNHTSNN
FERARFVFINKSILNQKN
>UU590 topA, DNA topoisomerase I
MQKDLIVVESPNKIKSIQSYLGDSYNVIATCGHLRELAKKSGYDPKTYDL
KWEIIKTTNKKLSKKQQIKTIIDLAKKSNNIYLATDPDREGEAISWHVYD
LLPKKDKERVKRITFNEITQKAILKSIDEKHDIDFNLVDSQFARRILDRV
IGYKLSGLVKKNLHGLSAGRVQSIALLFVVERELERRSFVKEEWYQIEGI
IEKNIFVSLRKIPYDVELYNQKDNSDSDLKFLHKKDAQRVIDDLSDIFKV
YSIDDLKITKGDVQLPLTTDKLLQIASNNFGWSANKTTLIAQQMFEGLEI
NNQQLALITYPRTDSERLSDDFLQEANAFIENNFGKEYLENFKNKKINRK
EVNIQDAHEAIRPVDINLKPEEIKDYVSLDIYKLYNLVWNKTLSALMKVP
TFNKQVIRFINNEYKFYTAYKTIRTLGYWILDFYKKQRDELEFQPPIINV
GDEFKKEKIDLIQKETTPPPYYTEASLIAALKNAGVGRPSTYATMATIGT
TRGYINKDKSKLIPTELGIKVIQELKEAFPKVISIKFTSEMEERLDVIAN
GKLFWKDLVSTFIPIFEEEVKQAYTKIEKVPDEKINRLCPICAHDLLIKR
SRMNTRFIACSNFPTCRFTESLEKPEILNELCPNCSKSLVKRKNRKNKYF
IGCTGYPECNFIRNLDESNNDKNDFNQ
>UU548 ung, uracil-DNA glycosylase
MKWKEFIINETKQSYLKNIIKKINNIENHQVVFPLKKQRFRCFDFFDIEQ
TKVVILGQDPYHTPKIANGLCFSVDLGNNLPGSLINIFKALEYDLQIKRT
NPDLSDWAKQGVLLLNTVLTVNAHQPNSHKNFGYEELIKNVFNELRKQKH
VVYLLWGKQAMSYINLIDQKQNLILCASHPSPLSAHRGFLTCKHFSKCND
YLIKHLRTPIKW
>UU102 uvrA, excinuclease ABC sununit A
MDKIIIKGARENNLKNIDLEIPKNKLVVITGVSGSGKSSLAFDTIFAEGK
RRYFESLSSYARQFLGGNDKADVESIEGLSPTIAVDQKSTNQNPRSIVGT
ITEIYDYLRVLFARVGTPFCPNGHGQIKSQTPKQIADFLFSLSPKSKIQI
LAPIEIKKGYKINDVLNNLRNQGYLRVLVNNEVYQLDENLPQFLDNKKTD
VAIIVDRLILNIDHQTKTRALDAIEFALNYSGGEIAFKVNDDIHYFTQND
VCQVCGFKIKEIEPTLFSFNSPIGACEQCKGLGYNYVPDERKMIPNPNLS
INEGGLDYFKNTVNTTNLDWQRFNSIIKHYKIDKTKPLKELDRKEIDLLL
YGSDEAIEIDITSANNKKYSSIDYVEGVLELVNRRYQETSSELAREHYNK
YMSEKVCKSCKGKKLSSQALSVLINKINIIDFIEKNIDEAIDFLLHLDLN
EAQTKIANPILKEVLDRLGFLKNVGLEYLTLARPASSLSGGEAQRIRLAT
QIGSKLTGILYVLDEPSIGLHQRDNDKLINTLKEMRDLGNTVIVVEHDEE
TMLAADYLIDIGPQAGVNGGYVIAAGTPQEVMQNPNSLTGQYLSKQKDIL
VPKTRRSGNGHKVILKGAKHNNLKNVDLTIPLGKFICVTGVSGSGKSSLI
LETLVKAIEYTNFNPFVIPGEYKDLIGASNVDKIVVVNQDAIGRTTRSNP
ATYVGVFDDIRTVFENTIEAKARGYSKSRFSFNIKGGRCERCWGDGTIRI
EMHFLPDVYISCEECHGKRYNDETLQVKFKGKSIYDVLKMPIDEALVFFE
NYPGIHRKLQLLVDVGLGYLELGASSTSLSGGEAQRIKLAKFLQRKPTGK
TLFVLDEPTTGLHIDDVAKLIKILDKIVDGGDTVLVIEHNLDLIKVADYI
IDIGPEGGNKGGKIIATGTPEQLLSKKDISYTAQYLEKYLKKN
>UU120 uvrB, excinuclease ABC subunit B
MDDFKKFELISDYKPAGDQQKAIDEMVNNINQGIQRQVLLGATGTGKTFS
VANVIAKTQLKTLVLAHNKTLAAQLFAELKEMFPHNKVEYFVSYFDYYQP
EAYKPITDTYIEKDSVTNAEIEMMRLSTINSLATRNDVIVVASVACIYAS
VSPIEFTKKNLYLHVGELIEFEQIKYKLVQLGYERKDYDLVPGTFRIRGD
LIEIMSGYSDKFKIRISMFGNEVESIDLCDPITNNIISKEQRFILRSASE
YIFDDSRLAIAIENIKNELDERVKFFLKNNQLIEAQRIEQRTKQDLESIV
EFGFCSGVENYYRHLEHREPFQTPWTIFDFFSYNNQDWLLIVDESHISLP
QVKGMHNTDRSRKQTLVEYGFRLPSALDNRPLNYDEFNKKLSKTIYVSAT
PNDEEIALSDNHIVSQIVRPTGLLDPIIEIRKTEHQIDDLINELMLLKNK
NQRAFITVMTIRMAEDLTNYLNNTKIKAAYLHNELKTLERSVIINKLRKG
IYDCVVGINLLREGLDVPEVAGVFIFDADKPGFFRSDKSLIQIIGRAARN
ADGKVIMYADVITQAMQTAINETKRRREIQLAFNLKHNIIPKTIIKPIHE
DLSGHDYKQNAELYAAKASKNEYNQKIKELKKKMEEAAKKREYEVAAQYR
DMIVELEAIKQSVKSK
>UU381 uvrC, excinuclease ABC subunit c
MNDLLKNKLKLIPHKPGCYLWKDQFNQIIYIGKAKDLYNRTHSYFNGCKD
NKTSKLVNNINDLEYIVVNNVNEALILENNLIKTHLPKYNILLKDGSNYP
YIMITNEQYPRLKYVRTYDKNKGIYFGPLADSTNKYQLFNLLNSIFPFNK
CNHQPYKKCIYYDLHQCINQVQQSTYQEAISEVKEIFKGNLDHILMILQT
KEQHAVTKLDFENAQKYAEQQKALTSIINSGLVQLDNNESFDIIGFYEKN
NYLVIIIFNYVKGKLLNKSADTFAIYDYEINELITSFLMQYYSQNKISSK
IIVSLDDDNLLALSQRFHTKFINAQTKFHKRILKLALDNAILYFESNIKN
VINKQNELDDALNQLKQILKLPDLNIIECFDNSNINLSLPIAGMIVYQNG
KLNNKLNRKYNLMTTKNASDYHFMIEVITRRYQRLVSQHQKLPNLIVVDG
GKLQVNAALYALAQLQINIPLIGLKKDQKHKTDAIVLTNGDEIVLDRKSI
LYKFLANMQNDVHNYAISFLRDKHTKSIFNSLLDNVQGLGKKRFNELLKY
YDSINDLKSASDQELLQFLPKNVLVNLREKLNKI
>UU501 uvrD, DNA helicase II
MGLGIDYSRLNQEQKEAVTADLGPQLVIAGAGTGKTSVLTLRIAYLITEK
NIHPSRILGFTFTNKAADEMKERVGKTIGVSIPYLSTFHSMCVKILQQDI
HYLNYHNNIKIIDTDDQEVLLKEIFDQLNIEKKSQVIKKIIKTISKVKNK
FFDQNDMLNEKNHKYLELVDLNDAQRLVDIYKIYCDRCFKLNYVDFDDLI
NLTHKLFIEFPEVLEKWQNKFDYILVDEFQDTNKIQYDLISLLATKHQNL
FVVGDPDQMIYSFRGAEQWIINNFSQNFKNTKVTILKTNYRSTQPILNTA
NRLIDANNNNYKKNLTAFNTNDNNLPIYLRGQNPIDEANWIARKIRELLE
EGTPANQIAVLFRSNHYSRTIEQSMMRESIPYTILGSKKFYERAEIKDMI
AYLKVVNDLDELSFLRIINTPRRAIGPTTFEHVKHYAINNNLFLFEALAE
VEKNHLINNTQKKNILNFVNLIKEIRDEMEDLKIHEILELIYKKVNYEAY
LLENEKAEDKIDNVYELKRAMKMYVDRHPDDTINDYLNSIALYLNKDGKD
SKENVLLMTVHNSKGLEYENVFVAGMNEGLLPSDRAINDDPIKGVEEERR
IAYVALTRAKKNLYISSACCYDPLARRQVFESRFINEIGFNNLKIINSSF
KNNKPEDMPLKSFLKQQEERSWFDSKQKQKEVEDNFYQTMKNDFEIGERI
VHTSFGDGVIIGIDGDILTIAFSKYRQPKQINFNHKTIVRRIG
>UU222 xerC, integrase-recombinase protein
MKDFIRYTKKRNLSLNTIRTYESVLKHYEPVLDSWIKIRNKIINSNFKPR
TIHLHKNVLLSFFEFKKLKRYLQNLKLLKLPQIEMKYFDVISKNNLYKKT
DILDDDSLEIKKYKTIIRFLFETGIRAHELFFLESINNRLYVLGKGNKKR
QIFFVKQTFEQLQKFYENLKGFETTKTLRLYIKKIIGKNFTPHSLRRSFA
TFMLIKGANPKTVMLQMGHANIQTTFSYLNLNEQTNRRIYNKIMYQNDAE